Literature DB >> 7078083

Distribution of mammary gland neoplasms and factors influencing metastases in hybrid mice.

W G Sheldon, K Owen, L Weed, R Kodell.   

Abstract

Mammary neoplasms in yellow (C3H x VY-A vy) F-1 virgin female mice with the murine mammary tumor virus were distributed equally between the left and right sides. The ratio of thoracic to inguinal gland involvement was 6.4 to 3.6 indicating that the A vy mutation, which enhances age-specific mammary tumor incidence, apparently does not affect the distribution of mammary tumors. The average tumor size was similar in all mammary glands. Multiple tumors occurred seven times more frequently in the thoracic than in the inguinal glands. Metastases occurred more frequently in moribund mice than in those killed at a scheduled time, and the incidence of pulmonary metastases in both groups was associated with the duration of the mammary tumors, their size, their location, and the number of neoplasms. Adenocarcinomas in the thoracic glands metastasized to the lungs more frequently than those in the inguinal glands.

Entities:  

Mesh:

Year:  1982        PMID: 7078083

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  4 in total

1.  In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.

Authors:  Sanaz A Jansen; Suzanne D Conzen; Xiaobing Fan; Erica Markiewicz; Thomas Krausz; Gillian M Newstead; Gregory S Karczmar
Journal:  NMR Biomed       Date:  2011-01-25       Impact factor: 4.044

Review 2.  Positional variations in mammary gland development and cancer.

Authors:  Jacqueline M Veltmaat; Ann F Ramsdell; Esta Sterneck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-05-12       Impact factor: 2.673

Review 3.  Embryonic Programs in Cancer and Metastasis-Insights From the Mammary Gland.

Authors:  May Yin Lee
Journal:  Front Cell Dev Biol       Date:  2022-06-29

4.  Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites.

Authors:  E N Unemori; N Ways; D R Pitelka
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.